Lv2
130 积分 2023-07-13 加入
Chemoproteomics-guided development of SLC15A4 inhibitors with anti-inflammatory activity
4个月前
已完结
Safety and efficacy of mirikizumab versus secukinumab and placebo in the treatment of moderate-to-severe plaque psoriasis (OASIS-2): a phase 3, multicentre, randomised, double-blind study
4个月前
已完结
Drug repurposing for glomerular diseases: an underutilized resource
4个月前
已完结
Sitravatinib is a potential EGFR inhibitor and induce a new death phenotype in Glioblastoma
4个月前
已完结
Targeting IL-23 for IBD: Rationale and Progress to Date
4个月前
已完结
Efficacy and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: results of the randomized, double‐blind, phase III NAVIGATE trial
4个月前
已关闭
How mutations shape p53 interactions with the genome to promote tumorigenesis and drug resistance
5个月前
已完结
Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
5个月前
已完结
Bispecific T cell engager therapy for refractory rheumatoid arthritis
5个月前
已完结
CD19 CAR T-Cell Therapy in Autoimmune Disease — A Case Series with Follow-up
5个月前
已完结
皖公网安备34019202002308
